Viewing nowSiglebe Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 202005195 · Approved 2020.07.20 · Insurance code 628901920
Improvement of blood glucose control in type 2 diabetes mellitus
This drug is used in conjunction with dietary and exercise therapy to assist in blood sugar control in patients with type 2 diabetes. It can also be administered alone, and in cases where sufficient blood sugar control is difficult with monotherapy and the patient has never been on diabetes medication, it can be used in combination with metformin. Additionally, in patients who have insufficient blood sugar control with mono therapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this drug may be added as an adjunct. Even in cases where blood sugar control is difficult despite the combination therapy of multiple drugs, this drug can improve blood sugar management. This drug effectively supports blood sugar control at various stages of treatment.
This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, reduction of the sulfonylurea or insulin dose may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dose adjustment according to renal function is required, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.
This medication may cause allergic reactions; therefore, if symptoms such as rash or difficulty breathing occur, stop taking the medication immediately and consult a doctor. This drug may cause serious pancreatic inflammation known as pancreatitis, so it is important to observe for abdominal pain, vomiting, or severe digestive symptoms during treatment and report them to medical personnel immediately. This drug is not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Patients who have had allergic reactions to this drug or its components should not take it. Patients with impaired kidney function should adjust the dosage of this drug, and it is important to receive regular kidney function tests. During the course of taking this drug, mild side effects such as cold symptoms, headache, and digestive discomfort may occur; if symptoms are severe or persist, inform your doctor. When taken in conjunction with insulin or other hypoglycemic agents like sulfonylureas, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently, and any symptoms should be promptly addressed. This drug is not recommended for pregnant or breastfeeding women, and its safety in children and adolescents under 18 years of age has not been established. Elderly patients may experience decreased kidney function, necessitating dosage adjustments and regular kidney function tests. In cases of overdose, appropriate medical action should be taken to remove the drug from the gastrointestinal tract and conduct an electrocardiogram; blood dialysis can help remove some of the drug. If symptoms such as joint pain or blisters on the skin occur during the course of taking this drug, consult a doctor immediately to determine whether to discontinue the medication. There are few significant interactions with other medications, but caution is needed when taking specific drugs, so inform your healthcare provider of all medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is well-ventilated, and the storage temperature should be kept between 1 and 30 degrees Celsius room temperature. This will help maintain the drug's effectiveness over time.
Light yellow pink, round, biconvex film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.